Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
220 Leser
Artikel bewerten:
(0)

Fifth Circuit Court of Appeals Upholds Cutting-Edge Protections for Women from Dangerous Chemical Abortion Drugs as well as Life-Saving Clinic Regulations

WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Americans United for Life President and CEO Dr. Charmaine Yoest applauded a decision by the Fifth Circuit Court of Appeals in which a Texas regulation of chemical abortion drugs and requirements for hospital admitting privileges were upheld, as the appeals court reversed the lower court decision in Planned Parenthood v. Gregory Abbott. "Women in Texas will now be protected from abortion industry misuse of life-ending drugs and will be provided greater protections from deadly events inside under-regulated, under-monitored and under-supervised clinics, run by profiteers," said Dr. Yoest. "I'm not surprised that an all-woman panel of judges understood the nuances of laws designed to protect women."

AUL filed an amicus brief in the case demonstrating that the Supreme Court supports regulating life-ending drugs that can harm women as well as end the lives of unborn children. The chemical abortion law was based in part on AUL's model legislation. Such legislative efforts to regulate deadly life-ending drugs are on the rise. Currently 14 states have laws regulating chemical abortion in varying degrees, while four more are exploring similar common-sense limits in 2014.

"The Fifth Circuit has affirmed the efforts of pro-life leaders in Texas who cared enough to work for common-sense protections for women," said Dr. Yoest. "We know that at least eight women have died of severe bacterial infection following their use of deadly, life-ending drugs when following abortion providers' off-label recommendations. Today's decision is a green light for other states to follow the lead of Texas and enact provisions prohibiting such misuse of dangerous abortion-inducing drugs."

Texas' chemical abortion regulation, along with a provision requiring abortion providers to have admitting privileges at a local hospital, were part of HB 2, a Texas bill passed during a special legislative session in 2013. Planned Parenthood challenged the provisions, and a federal district court ruled that the chemical abortion regulation posed an "undue burden" for some women.

Texas filed an expedited appeal with the Fifth Circuit, simultaneously asking that Circuit to postpone the district court's opinion and allow the laws to go into effect during the appeal. The Fifth Circuit agreed, and the U.S. Supreme Court denied an application by Planned Parenthood to reverse the Fifth Circuit's decision. Now the Fifth Circuit has given its final answer, upholding the state's regulation of chemical abortion and allowing Texas to protect women's health by reining in the abortion industry's misuse of abortion-inducing drugs.

AUL's amicus brief was filed on behalf of American Association of Pro-Life Obstetricians & Gynecologists, Christian Medical Association, Catholic Medical Association, Physicians for Life, National Association of Pro Life Nurses, National Association of Catholic Nurses, and The National Catholic Bioethics Center.

To learn more about the health risks of abortion to women, whether surgical or chemically induced, click here.

SOURCE Americans United for Life

© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.